We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
British Smaller Companies Vct Plc | LSE:BSV | London | Ordinary Share | GB0001403152 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 80.00 | 78.50 | 81.50 | 80.00 | 80.00 | 80.00 | 0.00 | 08:00:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 15.84M | 12.24M | 0.0507 | 15.78 | 192.99M |
TIDMBSV
RNS Number : 5620T
British Smaller Companies VCT PLC
20 March 2023
British Smaller Companies VCT plc
Interim Management Statement
For the quarter ended 31 December 2022
British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2022. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com .
Overview
In the quarter to 31 December 2022 the Company generated a Total Return of 4.3 pence per ordinary share, a 5.1 per cent increase on the net asset value (NAV) at the beginning of the quarter of 85.0 pence per share. The Company is now ranked first across all generalist VCTs when considering a blended average performance ranking over 1, 3, 5 and 10 years. Total Return is now 257.7 pence per share.
Performance
The table below sets out movements in key metrics for the Company.
Dividends 30 September Increase paid/shares Buyback Movement 31 December 2022 in Value issued of shares In Period 2022 Net Assets (GBPm) 158.1 8.0 (2.8) (0.6) 4.6 162.7 ------------- ---------- ------------- ----------- ----------- ------------ NAV per share (PPS) 85.0 4.3 (2.0) - 2.3 87.3 ------------- ---------- ------------- ----------- ----------- ------------ Cumulative dividends paid (PPS) 168.4 - 2.0 - 2.0 170.4 ------------- ---------- ------------- ----------- ----------- ------------ Total Return (PPS) 253.4 4.3 - - 4.3 257.7 ------------- ---------- ------------- ----------- ----------- ------------ Shares in issue 186,112,757 - 1,054,908 (775,240) 279,668 186,392,425 ------------- ---------- ------------- ----------- ----------- ------------
The unaudited NAV per ordinary share increased in value by 4.3 pence; after payment of 2.0 pence of dividends, NAV per ordinary share stood at 87.3 pence per share at the period end. Cumulative dividends paid at 31 December 2022 were 170.4 pence per ordinary share (30 September 2022: 168.4 pence per ordinary share).
The movements in NAV and NAV per ordinary share are set out in the table below:
GBPm Pence per ordinary share NAV at 30 September 2022 158.1 85.0 Increase in portfolio value 7.5 4.0 Net operating income 0.5 0.3 ---- ------- 8.0 4.3 Issue/buy-back of shares 0.3 - ---- ------- Total Return in the period 8.3 4.3 ---- ------ ------- --------- NAV before the payment of dividends 166.4 89.3 Dividends paid (3.7) (2.0) ---- ------ ------- --------- NAV at 31 December 2022 162.7 87.3 ------------------------------------- ---- ------ ------- ---------
Post-period end, on 11 January 2023, a special dividend of 4.5 pence per ordinary share for the year ending 31 March 2023 was paid, resulting in a corresponding reduction to the 31 December 2022 unaudited NAV, to 82.8 pence per ordinary share.
Net assets
Net assets at 31 December 2022 comprised the following:
GBP000 % of net assets Unquoted investments at fair value 114,101 70.1 Listed investment funds 4,269 2.6 Cash and cash equivalents 42,687 26.3 Other net assets 1,599 1.0 -------- --------- Net assets 162,656 100.0 ======== =========
Investments
Over the quarter to 31 December 2022, the aggregate unquoted portfolio valuation increased by GBP7.5 million. In December 2022, the Company completed the partial exit of its investment in planning and forecasting software and services business, Vuealta, through the sale of its fast-growing software division to long-standing partner, Anaplan. The sale generated proceeds of GBP4.6 million, 1.5x cost, and an uplift of 45 per cent, or GBP1.4 million, on the carrying value at the beginning of the year (including further investments made in the financial year prior to sale). The Company remains invested in the core Vuealta consulting business to support its next phase of growth.
During the quarter, the Company deployed GBP7.7 million into four new investments: AutomatePro (automated software testing), Biorelate (data curation software), Plandek (a software development analytics platform) and Summize (digital contracting software).
A number of investments within the portfolio are seeking to extend or accelerate their growth plans, which has resulted in further investment of GBP4.5 million into four portfolio companies in the period, including GBP2.7 million into Unbiased, to help the company's overseas expansion plans.
Subsequent to the period end, a further GBP3.6 million has also been invested into new investment DrDoctor, a patient engagement and communications software platform, taking the total invested so far this year to GBP24.2 million, following the GBP9.7 million invested in the full year to 31 March 2022.
The investment portfolio at 31 December 2022 comprised:
Cumulative valuation as a % Valuation of net GBP000 assets Matillion Limited 25,895 15.9% Outpost VFX Limited 9,302 21.6% Unbiased EC1 Limited 9,107 27.2% Displayplan Holdings Limited 7,630 31.9% Wooshii Limited 6,296 35.8% Elucidat Ltd 6,058 39.5% ACC Aviation Group Limited 5,340 42.8% Force24 Ltd 4,636 45.7% Vypr Validation Technologies Limited 3,897 48.1% SharpCloud Software Limited 3,763 50.4% 81,924 50.4% Other investments 32,177 70.1% Total investments 114,101 70.1% ========== ===========
Investments made since November 2015 represented 84 per cent of the value of the unquoted portfolio at 31 December 2022.
Shares in issue
The Company issued 1,054,908 ordinary shares under the Company's Dividend Re-investment Scheme (DRIS) following the payment of the interim dividend on 3 October 2022.
Under its standing buyback authority, on 16 December 2022 the Company purchased 775,240 shares at 75.08 pence at a cost of GBP0.58 million. These shares are held in treasury.
Subsequent to the quarter end, on 11 January 2023 the Company issued 2,507,454 shares under the DRIS following the payment of a special dividend, taking the number of shares in issue at that date to 188,899,879, with a further 20,787,165 shares held in treasury.
Fundraising
On 30 November 2022, the Company announced a new share offer, alongside British Smaller Companies VCT2 plc, with the intention of raising up to GBP75 million in aggregate, which included an over-allotment facility of GBP25 million. Gross Applications exceeding GBP62.5 million have been received as at the date of this report, of which GBP39 million relate to the Company. The related allotment will take place in early April 2023.
Outlook
The positive performance of the portfolio in the quarter is pleasing in what remains a tough economic environment. Portfolio companies continue to show great resilience, with key investments demonstrating robust revenue growth.
We thank both existing and new shareholders for their support of the Company's current fundraising. We are continuing to see promising new investment prospects, as well as opportunities to deploy funds into the existing portfolio to help them accelerate their growth plans. We look forward to updating investors on our progress in investing the funds raised in the coming quarters.
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.
20 March 2023
For further information please contact:
David Hall YFM Private Equity Limited Tel: 0113 244 1000
Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
QRTEALDEADADEFA
(END) Dow Jones Newswires
March 20, 2023 11:00 ET (15:00 GMT)
1 Year British Smaller Companie... Chart |
1 Month British Smaller Companie... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions